Jiqian Xu
- Infectious Diseases top 0.1%
- Neurology top 0.2%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 2%
- Epidemiology top 5%
- Topics
- COVID-19 Clinical Research Studies (8 papers)Sepsis Diagnosis and Treatment (8 papers)Respiratory Support and Mechanisms (6 papers)
- Journals
- ACS NanoPLoS ONEScientific Reports
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiqian Xu
34 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Infectious Diseases 5.2k
- Neurology 2.8k
- Pulmonary and Respiratory Medicine 1.3k
- Oncology 1.3k
- Epidemiology 953
Countries citing papers authored by Jiqian Xu
This map shows the geographic impact of Jiqian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiqian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiqian Xu more than expected).
Fields of papers citing papers by Jiqian Xu
This network shows the impact of papers produced by Jiqian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiqian Xu. The network helps show where Jiqian Xu may publish in the future.
Co-authorship network of co-authors of Jiqian Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jiqian Xu. A scholar is included among the top collaborators of Jiqian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiqian Xu. Jiqian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 12 | |
| 5 | 16 | |
| 6 | 18 | |
| 7 | 21 | |
| 8 | 40 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 21 | |
| 12 | 18 | |
| 13 | 1 | |
| 14 | 31 | |
| 15 | 34 | |
| 16 | Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studybreakdown → | 6803 |
| 17 | 46 | |
| 18 | 18 | |
| 19 | 39 | |
| 20 | 58 |
About Jiqian Xu
Jiqian Xu is a scholar working on Critical Care and Intensive Care Medicine, Anesthesiology and Pain Medicine and Developmental Neuroscience, having authored 35 papers that have together received 7.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Sepsis Diagnosis and Treatment (8 papers) and Respiratory Support and Mechanisms (6 papers). The work is most often cited by research in Infectious Diseases (5.2k citations), Neurology (2.8k citations) and Critical Care and Intensive Care Medicine (742 citations). Jiqian Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include You Shang, Xiaobo Yang, Yaxin Wang, Yu Yuan, Yongran Wu, Shangwen Pan, Huaqing Shu, Xiaojing Zou, Shiying Yuan and Hong Liu. Their work appears in journals such as ACS Nano, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.